China Pharma Holdings, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2022
Total Assets: $17.8M
Liabilities Breakdown FY2022
Total Liabilities: $13.5M
Asset Breakdown
Total Assets: $17.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.0M | 11.4% |
| Accounts Receivable | $421.5K | 2.4% |
| Inventory | $2.9M | 16.6% |
| Property, Plant & Equipment | $10.0M | 56.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $1.8M | 10.2% |
| Other Assets | $604.3K | 3.4% |
Liabilities Breakdown
Total Liabilities: $13.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $667.1K | 4.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $12.8M | 95.1% |